ASTX660
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for ASTX660, covering 2024-08-02 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]